secwatch.observer — SEC 8-K summary
======================================

Issuer:     Amneal Pharmaceuticals, Inc. (AMRX)
CIK:        0001723128
Form:       8-K
Filed at:   2023-05-12T23:59:59+00:00
Accession:  0001723128-23-000023
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Amneal shareholders elect all director nominees, approve compensation and incentive plan
--------------------------------------------------------------------------------

- All 11 director nominees elected with at least 84% of votes cast in favor.
- Advisory say-on-pay proposal approved with 97.4% of votes cast in favor.
- Ratification of Ernst & Young as auditor approved with 99.4% of votes cast.
- Amended & Restated 2018 Incentive Award Plan approved with 93.3% of votes cast.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1723128/000172312823000023/0001723128-23-000023-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1723128/000172312823000023/amrx-20230509.htm
  HTML page:      https://secwatch.observer/filing/0001723128-23-000023

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer